(Q40224641)

18 September 2017

AKT activity regulates the ability of mTOR inhibitors to prevent angiogenesis and VEGF expression in multiple myeloma cells (English)

1 reference

18 September 2017

Frost P

1

1 reference

18 September 2017

Shi Y

series ordinal

2

1 reference

18 September 2017

Hoang B

series ordinal

3

1 reference

18 September 2017

Lichtenstein A

series ordinal

4

1 reference

18 September 2017

language of work or name

English

0 references

publication date

2 October 2006

1 reference

18 September 2017

1 reference

18 September 2017

26

1 reference

18 September 2017

2255-2262

1 reference

18 September 2017

16

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.onc.1210019

18 September 2017

0 references

cites work

Regulation of vascular endothelial growth factor (VEGF) expression is mediated by internal initiation of translation and alternative initiation of transcription.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210019

The activation of p38 and apoptosis by the inhibition of Erk is antagonized by the phosphoinositide 3-kinase/Akt pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210019

Assessing IRES activity in the HIF-1alpha and other cellular 5' UTRs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210019

The TOR pathway: a target for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210019

Frequent translocation t(4;14)(p16.3;q32.3) in multiple myeloma is associated with increased expression and activating mutations of fibroblast growth factor receptor 3

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210019

Members of the poly (rC) binding protein family stimulate the activity of the c-myc internal ribosome entry segment in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210019

In vivo antitumor effects of the mTOR inhibitor CCI-779 against human multiple myeloma cells in a xenograft model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210019

AKT activity determines sensitivity to mammalian target of rapamycin (mTOR) inhibitors by regulating cyclin D1 and c-myc expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210019

Biologic sequelae of interleukin-6 induced PI3-K/Akt signaling in multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210019

The AKT kinase is activated in multiple myeloma tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210019

Activation of hypoxia-inducible transcription factor depends primarily upon redox-sensitive stabilization of its alpha subunit

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210019

Two independent internal ribosome entry sites are involved in translation initiation of vascular endothelial growth factor mRNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210019

Effect of thalidomide therapy on bone marrow angiogenesis in multiple myeloma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210019

Hypoxia-inducible factor-1alpha mRNA contains an internal ribosome entry site that allows efficient translation during normoxia and hypoxia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210019

HER2 (neu) signaling increases the rate of hypoxia-inducible factor 1alpha (HIF-1alpha) synthesis: novel mechanism for HIF-1-mediated vascular endothelial growth factor expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210019

The vascular endothelial growth factor mRNA contains an internal ribosome entry site.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210019

Enhanced sensitivity of PTEN-deficient tumors to inhibition of FRAP/mTOR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210019

eIF4E activity is regulated at multiple levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210019

Cyclin D1 and c-myc internal ribosome entry site (IRES)-dependent translation is regulated by AKT activity and enhanced by rapamycin through a p38 MAPK- and ERK-dependent pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210019

Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210019

Analysis of the c-myc IRES; a potential role for cell-type specific trans-acting factors and the nuclear compartment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210019

Mechanism by which mammalian target of rapamycin inhibitors sensitize multiple myeloma cells to dexamethasone-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210019

Messenger RNA translation state: the second dimension of high-throughput expression screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210019

Prognostic value of angiogenesis in solitary bone plasmacytoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210019

Vascular endothelial growth factor triggers signaling cascades mediating multiple myeloma cell growth and migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210019

7 January 2021

inferred from DOI database lookup

Serum levels of the angiogenic cytokines basic fibroblast growth factor (bFGF), vascular endothelial growth factor (VEGF) and hepatocyte growth factor (HGF) in multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210019

7 January 2021

inferred from DOI database lookup

Excessive survivin expression in thyroid lymphomas

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210019

7 January 2021

inferred from DOI database lookup

Identifiers

DOI

10.1038/SJ.ONC.1210019

1 reference

Dimensions Publication ID

18 September 2017

1016357205

0 references

Fatcat ID

release_ibgfsezuybdcfeiwhmqun5wpty

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ibgfsezuybdcfeiwhmqun5wpty

24 November 2022

mapped directly with Wikidata item

1 reference